BULLOUS PEMPHIGOID (BP)

Clinical trials for BULLOUS PEMPHIGOID (BP) explained in plain language.

Never miss a new study

Get alerted when new BULLOUS PEMPHIGOID (BP) trials appear

Sign up with your email to follow new studies for BULLOUS PEMPHIGOID (BP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New shot could help patients with severe blistering skin disease ditch steroids

Disease control Not yet recruiting

This study tests an injection called stapokibart for people with moderate to severe bullous pemphigoid, a painful blistering skin condition. The goal is to see if it can help patients stop taking steroids and keep the disease under control for 36 weeks. About 200 adults aged 18 t…

Matched conditions: BULLOUS PEMPHIGOID (BP)

Phase: PHASE3 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC

BULLOUS PEMPHIGOID (BP)

Get alerted when new BULLOUS PEMPHIGOID (BP) trials appear

New shot could help patients with severe blistering skin disease ditch steroids